Background
==========

Esophageal cancer is an increasingly common cancer with a poor prognosis. Its incidence has risen steadily over recent decades, and it is now the fastest rising solid tumor in most Western countries \[[@B1]\]. Nowadays, combined modality treatment protocols, such as neoadjuvant radiation and/or chemotherapy followed by esophagectomy, are the standard treatment since meta-analyses of randomized trials have found some survival advantages \[[@B2]\], especially in patients with a complete pathologic response to neoadjuvant therapy \[[@B3]\]. In a very recent and authoritative randomized controlled study, preoperative chemoradiotherapy was shown to improve survival among patients with potentially curable esophageal or esophagogastric-junction cancer \[[@B4]\]. Nevertheless, in spite of a limited (25% to 35%) possibility of cure and its association with a high risk of serious complications \[[@B5]\], esophagectomy remains part of the standard treatment for patients presenting with resectable esophageal cancer \[[@B6]\].

Postoperative management of patients undergoing esophagectomy is particularly challenging, requiring special expertise that can be found mainly in high volume centers \[[@B7]\]. In fact, the risk of severe postoperative complications is high even in specialized centers \[[@B6]\]; moreover, postoperative pain can heavily affect postoperative quality of life \[[@B8]\]. Sleep disruption by painful stimuli is frequently observed both in clinical and experimental conditions \[[@B9]\]. Furthermore, in spite of recent evidence showing that an early removal does not affect anastomotic outcome, a nasogastric tube is usually kept in place for the first 7 to 10 postoperative days causing constant discomfort \[[@B10]\]. Finally, after esophagectomy patients usually spend at least 2 days in the ICU, where noise and full light are almost constant throughout the day. A recent study showed that a range of hospital sounds have a high disruptive capacity on sleep, influencing both cortical brain activity and cardiovascular function \[[@B11]\]. All these premises suggest that patients undergoing esophagectomy would need hypnotic drugs to cope with postoperative sleep disturbances.

In a recent systematic review, we observed that, in the early postoperative period following esophagectomy, patients experience a significantly worsened global quality of life and are affected by more fatigue \[[@B12]\]. Moreover, we observed that postoperative pain, and its relief, are the main predictors of early postoperative quality of life after esophagectomy \[[@B8]\]. Therefore, the aims of this prospective study were to analyze the predictors of postoperative sleep disturbance after esophagectomy for cancer and to identify patients at risk for postoperative hypnotic administration.

Methods
=======

Study design
------------

Data from a prospectively collected database including all consecutive patients presenting with esophageal cancer at a tertiary referral center (the Surgical Oncology Unit of the Veneto Institute of Oncology, Padova, Italy) between May 2011 and September 2012, were reviewed. Clinical and socio-demographic data including age, sex, the type and timing of procedures carried out, and pre- and postoperative drug administration were prospectively recorded. The Clavien-Dindo classification of surgical complications was adopted for the classification of adverse events after surgery. Tumor-node-metastasis (TNM) staging was performed according to the most recent criteria of the International Union Against Cancer. Details concerning neoadjuvant therapy and surgical techniques have been published elsewhere \[[@B13]\]. The EORTC QLQ-C30, a measure assessing the quality of life of cancer patients, was administered to patients presenting to our outpatient clinic following neoadjuvant therapy at hospital admission for surgery and at hospital discharge. The study was performed according to the principles of the Declaration of Helsinki and all the patients gave their informed consent to data collection and study participation. The study was approved by the Ethical Committee of the Veneto Institute of Oncology (IOV-IRRCS) (internal code 2012/46). The study design is outlined in Figure [1](#F1){ref-type="fig"}.
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Administration of drugs influencing sleep during the postoperative period
-------------------------------------------------------------------------

During ICU stay, pain killers, inotropics, peridural anesthetic infusion, and hypnotic drug administration were monitored and quantified. Standard pain control protocol included naropine 0.2% epidural infusion (5 mL/h) and acetaminophen 1 g i.v. tris in die. Opioids (tramadol 100 mg or morphine 5 mg) were administered if pain persisted and, thus, upon the patients' request. Benzodiazepines (lorazepam 2.5 mg, diazepam 10 mg, or lormetazepam 0.5 mg) were offered for insomnia to every patient and administered upon the patients' request. The administration of pain killers or hypnotics upon request was registered on the clinical records by the nurse in charge. The daily dose requested was calculated.

Quality of life questionnaire
-----------------------------

The EORTC QLQ-C30 is a 30-item integrated system for assessing the generic quality of life of cancer patients \[[@B14]\]. The validity and robustness of the Italian version of the EORTC QLQ-C30 were assessed in a large series of cancer patients in 1998 \[[@B15]\]. It is grouped into five functional subscales (role, physical, cognitive, emotional, and social functioning) and two questions assessing overall quality of life. In addition, there are multi-item symptom scales (sleep, fatigue, pain, and nausea and vomiting). All of the scales and single-item measures range in score from 0 to 100. A high score for a functional scale represents a high/healthy level of functioning, a high score for the global health status/quality of life represents a high quality of life, and a high score for a symptom scale/item represents a high level of symptomatology/problems. The questionnaire has been validated into the Italian language.

Statistical analysis
--------------------

All statistical analyses were performed using the statistic program STATISTICA 5.1 for Windows 7 (Statsoft Inc.). The scores on the EORTC questionnaires were calculated according to the standard Quality of Life Group guidelines. The mean (95% CI) or frequency (%) was used for descriptive statistics unless otherwise described. Comparisons and correlations were carried out with Friedman ANOVA for paired multiple comparisons, Mann--Whitney U-test for unpaired comparison, and Kendall correlation test, respectively. Multiple regression models were created with significant predictors to determine the independent contributions of the different item scores. Receiving operator characteristics (ROC) were assessed by curve analysis. All tests were two-sided and a *P* value less than 0.05 was considered significant.

Results
=======

Administration of drugs influencing sleep during the postoperative period
-------------------------------------------------------------------------

The patient, treatment, and cancer characteristics are outlined in Table [1](#T1){ref-type="table"}. The median ICU stay was 2 (1--8) days long and the median epidural catheter stay was 5.2 (0--13) days long. The median infusion length was 180 (0--5,040) minutes for dopamine, 86 (0--2,110) for noradrenaline, and 8.5 (0--375) minutes for dobutamine. Four patients required benzodiazepines during the ICU stay. Once returned in the surgical ward, the mean daily request of diazepam, lormetazepam, and lorazepam was 0.069 (95% CI: 0.032--0.106), 0.021 (95% CI 0.002--0.040), and 0.269 (95% CI 0.186--0.351) doses, respectively. The overall benzodiazepine daily need was 0.358 (95% CI 0.278--0.439). Administration of drugs influencing sleep during the postoperative period is shown in Figure [2](#F2){ref-type="fig"}.

###### 

Patient and cancer characteristics

  **Patient characteristics**                                                     
  ----------------------------- ------------------------------------------------- -----------------------
  Demographics                  Gender                                            13 F/49 M
                                Age (years)                                       60 (27--84)
  Symptoms at diagnosis         Weight loss (kg)                                  4.5 (0--22)
                                Dysphonia (pts)                                   7 (11.3%)
                                Pain (pts)                                        33 (53.2%)
                                Burning (pts)                                     11 (17.7%)
                                Reflux (pts)                                      18 (29.0%)
  Comorbidities                 Cardiologic comorbidities                         32 (51.6%)
                                Pulmonary comorbidities                           14 (22.6%)
                                Hepatic comorbidities                             3 (4.8%)
                                Psychiatric comorbidities                         2 (3.2%)
  **Cancer characteristics**                                                      
  Cancer site                   Upper esophagus (pts)                             2 (3.2%)
                                Medium esophagus (pts)                            8 (12.9%)
                                Lower esophagus (pts)                             52 (83.9%)
  Histotype                     Adenocarcinoma (pts)                              43 (69.4%)
                                Squamous cell carcinoma (pts)                     19 (30.6%)
  Pathological stage                                                              
  pT (pts)                      pN (pts)                                          pM (pts)
  T0 12                         N0 34                                             M0 59
  T1 10                         N1 12                                             M1 3
  T2 9                          N2 6                                               
  T3 26                         N3 8                                               
  T4 5                                                                             
  **Esophagectomy**                                                                
  Surgical details              Cervical anastomosis/thoracic anastomosis (pts)   14 (22.6%)/48 (77.4%)
                                Laparoscopy (pts)/thoracoscopy (pts)              6 (9.7%)/2 (3.2%)
                                Feeding jejunostomy (pts)                         31 (50%)
                                Performing time (min)                             428 (210--695)
                                Selective lung exclusion (when performed) (min)   166 (65--390)
  Esophagectomy complications   Anastomotic leaks (pts)                           3 (4.8%)
                                Cardiologic complication (pts)                    7 (11.3%)
                                Pulmonary complications (pts)                     13 (21.0%)
                                Urinary complication (pts)                        4 (6.5%)
                                Recurrent nerve lesions (pts)                     4 (6.5%)
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Quality of life during treatment for cancer-related esophagectomy
-----------------------------------------------------------------

In our study group, the global quality of life and emotional functioning remained stable during the three steps of the study. On the contrary, pain and sleep disturbance significantly increased after surgery compared to after neoadjuvant therapy and at diagnosis (*P* = 0.01 and *P* = 0.001, respectively). Similarly, fatigue tended to increase after esophagectomy compared to after neoadjuvant therapy and at diagnosis (*P* = 0.07). The quality of life changes during the three steps of the study are shown in Figure [3](#F3){ref-type="fig"}a.
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Quality of life and request of drugs influencing sleep
------------------------------------------------------

In multivariate analysis, a daily request of hypnotics was an independent predictor of poor quality of life outcome (β = −0.297, *P* = 0.022). Emotional function after esophagectomy was independently predicted by the daily request of tramadol, the previous use of benzodiazepine, and the daily request of benzodiazepines (β = −0.354, *P* = 0.004; β = −0.335, *P* = 0.006; β = −0.242, *P* = 0.043, respectively). Fatigue after esophagectomy was independently predicted by sleep disturbance after neoadjuvant therapy and the daily request of benzodiazepines (β = 0.399, *P* = 0.008 and β = 0.288, *P* = 0.051, respectively). Sleep disturbance after esophagectomy was independently predicted by the duration of dopamine infusion in the ICU and the daily request of benzodiazepines (β = 0.236, *P* = 0.049 and β = 0.318, *P* = 0.010, respectively). The correlations between drugs influencing sleep administration and quality of life following surgery are outlined in Table [2](#T2){ref-type="table"}.

###### 

Predictors of global quality of life and of sleep disturbance

  --------------------------------------------------------------------------- ----------------- -------------- --------------------------- --------------
  **Global quality of life after surgery predictors (R**^**2**^ **= 0.10)**    **Kendall's τ**   ***P*value**   **Multiple regression β**   ***P*value**
  Duration of fentanest infusion in ICU                                            −0.199           0.028                −0.148                0.244
  Duration of dopamine infusion in ICU                                             −0.208           0.022                                         
  Daily request of hypnotics in surgical ward                                      −0.238           0.008                −0.297                0.022
  **Fatigue after surgery R**^**2**^ **= 0.28**                                **Kendall's τ**   ***P*value**   **Multiple regression β**   ***P*value**
  Daily request of benzodiazepine in surgical ward                                  0.219           0.012                 0.288                0.051
  Sleep disturbance at admission                                                    0.257           0.018                 0.399                0.008
  Postoperative cardiologic complications                                           0.186           0.033                                         
  Duration of right lung exclusion                                                  0.187           0.036                                         
  **Emotional function after surgery R**^**2**^ **= 0.30**                     **Kendall's τ**   ***P*value**   **Multiple regression β**   ***P*value**
  Daily request of tramadol in surgical ward                                       −0.211           0.019                −0.354                0.004
  Previous use of benzodiazepine                                                   −0.255           0.005                −0.335                0.006
  Daily request of benzodiazepine in surgical ward                                 −0.275           0.002                −0.242                0.043
  Duration of dopamine infusion in ICU                                             −0.205           0.024                −0.133                0.257
  **Pain after surgery R**^**2**^ **= 0.24**                                   **Kendall's τ**   ***P*value**   **multiple regression β**   ***P*value**
  Cardiologic comorbidities                                                        −0.304           0.001                −0.375                0.002
  Maximum PEEP used in ICU                                                         −0.224           0.016                −0.210                0.081
  Duration of fentanest infusion in ICU                                             0.179           0.050                 0.220                0.066
  Daily request of benzodiazepine in surgical ward                                  0.187           0.040                 0.157                0.189
  **Sleep disturbance after surgery R**^**2**^ **= 0.23**                      **Kendall's τ**   ***P*value**   **multiple regression β**   ***P*value**
  Daily request of benzodiazepine in surgical ward                                  0.286           0.002                 0.318                0.010
  Previous use of benzodiazepine                                                    0.260           0.004                 0.234                0.052
  Emotional functioning after surgery                                              −0.197           0.030                                         
  Duration of dopamine infusion in ICU                                              0.198           0.031                 0.236                0.049
  Psychiatric comorbidities                                                         0.245           0.007                                         
  Pain after surgery                                                                0.198           0.031                 0.231                0.057
  --------------------------------------------------------------------------- ----------------- -------------- --------------------------- --------------

Finally, patients who needed hypnotics during their postoperative period in the surgical ward had a significantly worse global quality of life compared to patients who did not need them (*P* = 0.007). Moreover, they reported a worse emotional function, fatigue, and pain (*P* = 0.03, *P* = 0.01, and *P* = 0.04, respectively). Curiously, in spite of the use of hypnotics, these patients tended to have a worse sleep disturbance (postoperative SL item) (*P* = 0.08). The effect of hypnotic administration on postoperative quality of life is shown in Figure [3](#F3){ref-type="fig"}b.

Predictors of hypnotic administration in the postoperative period
-----------------------------------------------------------------

In multivariate analysis, only sleep disturbance at diagnosis proved to be an independent predictor of postoperative request of any kind of hypnotic (β = 0.472, *P* = 0.011). ROC curve analysis showed that sleep disturbance at diagnosis was a relatively good predictor of postoperative request of any kind of hypnotic (area under the curve (AUC) of 69%, *P* = 0.08). Similarly, only sleep disturbance at diagnosis proved to be an independent predictor of postoperative benzodiazepine request (β = 0.647, *P* \<0.001). ROC curve analysis showed that sleep distubance at diagnosis was a good predictor of postoperative benzodiazepines (AUC = 73%, *P* = 0.02). Predictors of hypnotic administration in the postoperative period are shown in Figure [4](#F4){ref-type="fig"}.
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Discussion
==========

Postoperative management of patients undergoing esophagectomy is particularly challenging \[[@B7]\]. In fact, apart from the risk of severe postoperative complications, postoperative pain, fatigue, and sleep disturbances can heavily affect a patient's postoperative quality of life \[[@B8]\]. Following esophagectomy, sleep disruption can occur because of painful stimuli \[[@B9]\], constant discomfort caused by the nasogastric tube \[[@B10]\], and the constant noise and light in the ICU. Moreover, in the long term, almost all post-esophagectomy patients experience some kind of reflux when supine and heartburn may make it difficult for patients to lie flat causing sleep disruption \[[@B16]\]. All these premises suggest that patients undergoing esophagectomy would require hypnotic drugs to cope with postoperative sleep disturbances. Therefore, the aim of this prospective study was to analyze how hypnotic and vasopressor administration affects postoperative sleep disturbance and quality of life following cancer-related esophagectomy.

In our series, patients spent, on average, 2 days in the ICU, where lights are often on for several hours per night. The role of the pineal gland is to translate light inputs from the retina into chemical signals for the rest of the body via production and secretion of melatonin to regulate the sleep/wake cycle. Melatonin production occurs on a night/day cycle and is heavily dependent on the concentration of serotonin \[[@B17],[@B18]\]. Moreover, during ICU stay, patients often underwent inotrope and vasopressor infusion for cardiovascular support. The use of inotropes or vasopressors in the ICU has previously been correlated with post-discharge anxiety \[[@B19]\]. Intravenous dopamine does not pass the blood--brain barrier; however, unlike much of the rest of the mammalian brain, the pineal gland is not isolated from the body by the blood--brain barrier system and it has profuse blood flow, second only to the kidney. Recently, a new role for the D4 dopamine receptor in the pineal gland was observed: by means of a circadian-related heteromerization with adrenergic receptors their activation can limit the levels of melatonin secreted by the pineal gland \[[@B20]\]. The anatomic consideration and this new interesting observation might explain why, in our series, dopamine infusion in the ICU proved to be an independent predictor of sleep disturbance following esophagectomy.

In our series, sleep disturbance was significantly increased after surgery compared to baseline and it was independently predicted not only by the length of dopamine infusion but also, as expected, by daily request of benzodiazepines. Therefore, since in our series hypnotics were liberally administered upon the patients' request after having reported insomnia, daily request of sedative hypnotics can be easily considered a marker of sleep disturbance. Four patients required benzodiazepines during ICU stay, and, once they returned to the surgical ward, the mean overall daily request of benzodiazepine was 35% of a dose and 40% for the hypnotic dose. However, in spite of the availability and the liberal use of hypnotics, these patients tended to experience worse sleep disturbances in the early postoperative period. Thus, the first take-home message is that, in the postoperative period, administration of hypnotics upon request does not completely fulfil its goal. Further strategies to manage postoperative insomnia following such a major surgery are warranted.

Moreover, it was already known that the administration of hypnotics, such as melatonin, following minimally invasive abdominal surgery, did not improve subjective sleep quality or well-being compared with placebo \[[@B21]\]. Even worse, in our observational series, we noted that patients requiring hypnotics in the surgical ward reported an impaired emotional function and global quality of life and worse fatigue and pain compared to patients who did not need them. Daily request of benzodiazepines in the postoperative period after esophagectomy was an independent predictor of impaired emotional function and increased fatigue. A strong association between depression at 3 months and receiving benzodiazepines in the ICU has been previously observed by Wade et al. \[[@B19]\]. However, the underlying mechanism is not clear since confounding factors might be associated with this phenomenon. Fatigue following esophagectomy was also predicted by sleep disturbance after neoadjuvant therapy and emotional function was also predicted by the daily request of tramadol; thus, sleep disturbances alone and postoperative pain may play a direct role on postoperative impairment of these quality of life aspects. Nevertheless, since daytime drowsiness and fatigue are well known short term side effects \[[@B22]\], and severe anxiety and depression and even suicide disturbances might be long term bad outcomes \[[@B23],[@B24]\] of benzodiazepine use, the suspicion of a possible causative relation cannot be excluded. Therefore, although these findings should be interpreted cautiously given that hypnotics were not randomly assigned but were rather administered upon patient request, at clinician discretion, alternative treatments of postoperative insomnia should be initiated as first-line treatments in most patients \[[@B25]\].

These considerations make it necessary to identify patients at risk of sleep disturbance who might benefit from a preventive medical therapy or non-pharmacologic intervention \[[@B25]\]. In our series, postoperative daily hypnotics need and, in particular, daily benzodiazepine need in the surgical ward were independently predicted by the sleep disturbance item at diagnosis, although the accuracy of these predictions was not high but acceptable. This simple tool (a single question investigating the presence of sleep disturbance in the previous week) might be used to quickly screen patients for whom esophagectomy may be a therapeutic option. Once they are admitted for the operation they may have a better management of postoperative insomnia.

Conclusions
===========

In conclusion, the use of vasopressors in the ICU affects sleep in the subsequent postoperative period, and the use of hypnotics and, in particular, of benzodiazepines is neither completely successful nor lacking in possible consequences in terms of impaired emotional function and quality of life and worse postoperative fatigue and pain. The sleep disturbance item at diagnosis can successfully predict patients who can develop sleep disturbances during their postoperative period and can be used as a quick screening test to plan further interventions that might help reduce poor outcomes following esophagectomy.
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